Aldesleukin Terminated Phase 4 Trials for Metastatic Melanoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01856023HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma